!-- Global site tag (gtag.js) - Google Analytics -->

ENTHEON BIOMEDICAL

A new dimension in addiction treatment

Latest News Release

Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Psychedelics Today

Expanding brand awareness and access to HaluGen's Psychedelics Genetic Test Kit

Read Now
PAST RELEASES
See all releases

Entheon is in a unique position to challenge the narrative and expectations around addiction recovery.

Leveraging emerging bio-technology, we are pioneering a leading-edge addiction recovery solution that harnesses the therapeutic potential of patient-centric psychedelic medicine to remedy the underlying causes of Substance Use Disorder. Focusing primarily on the powerful DMT molecule, Entheon exists to invert the addiction recovery ratio, turning the ‘untreatable case’ and ‘lost cause’ from the norm to the exception.